数字乳腺断层合成联合超声与数字乳腺X线摄影联合超声在致密型乳腺女性乳腺癌筛查中的比较
该回顾性匹配队列研究比较了致密型乳腺女性中数字乳腺断层合成(DBT)联合全乳超声与数字乳腺X线摄影(DM)联合全乳超声的筛查效果,共匹配863例DBT组与1726例DM组女性。DBT组与DM组的癌检出率相当(10.4 vs 9.8/1000次检查,P=0.889),但DBT组异常解读率更高(31.6% vs 22.4%,P<0.001),特异性更低。
要点
- 致密型乳腺女性中,DBT+超声与DM+超声的癌检出率相当(10.4 vs 9.8/1000次检查,P=0.889)。
- DBT+超声的异常解读率高于DM+超声(31.6% vs 22.4%,P<0.001),特异性更低。
- DBT或DM阴性后补充超声,两组补充检出率相似(4.0 vs 3.3/1000次检查,P=0.803),但DBT组补充超声的异常解读率更高(24.8% vs 16.9%,P<0.001)。
核心结论
- 在致密型乳腺女性中,DBT筛查联合超声与DM筛查联合超声的癌检出率相当,但DBT联合超声的特异性低于DM联合超声。
研究设计与样本
- 回顾性数据库搜索纳入2016年6月至2019年7月间同时接受DBT或DM及全乳超声筛查的连续无症状致密型乳腺女性,按乳腺密度、年龄、绝经状态、激素替代治疗及乳腺癌家族史以1:2比例匹配DBT+超声组(863例)与DM+超声组(1726例),中位年龄53岁(四分位距40-78岁)。
诊断标准与关键数值
- DBT组癌检出率10.4/1000次检查(9/863,95%CI 4.8-19.7) vs DM组9.8/1000次检查(17/1726,95%CI 5.7-15.7),P=0.889;DBT组异常解读率31.6%(273/863,95%CI 28.5%-34.9%) vs DM组22.4%(387/1726,95%CI 20.5%-24.5%),P<0.001;两组敏感度均为100%。
临床应用与阅片要点
- 在DBT或DM阴性后补充超声,DBT组补充癌检出率4.0/1000次检查 vs DM组3.3/1000次检查(P=0.803),DBT组补充超声异常解读率24.8%(188/758,95%CI 21.8%-28.0%) vs DM组16.9%(257/1516,95%CI 15.1%-18.9%),P<0.001。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To compare the outcomes of digital breast tomosynthesis (DBT) screening combined with ultrasound (US) with those of digital mammography (DM) combined with US in women with dense breasts.
MATERIALS AND METHODS: A retrospective database search identified consecutive asymptomatic women with dense breasts who underwent breast cancer screening with DBT or DM and whole-breast US simultaneously between June 2016 and July 2019. Women who underwent DBT + US (DBT cohort) and DM + US (DM cohort) were matched using 1:2 ratio according to mammographic density, age, menopausal status, hormone replacement therapy, and a family history of breast cancer. The cancer detection rate (CDR) per 1000 screening examinations, abnormal interpretation rate (AIR), sensitivity, and specificity were compared.
RESULTS: A total of 863 women in the DBT cohort were matched with 1726 women in the DM cohort (median age, 53 years; interquartile range, 40-78 years) and 26 breast cancers (9 in the DBT cohort and 17 in the DM cohort) were identified. The DBT and DM cohorts showed comparable CDR (10.4 [9 of 863; 95% confidence interval {CI}: 4.8-19.7] vs. 9.8 [17 of 1726; 95% CI: 5.7-15.7] per 1000 examinations, respectively; P = 0.889). DBT cohort showed a higher AIR than the DM cohort (31.6% [273 of 863; 95% CI: 28.5%-34.9%] vs. 22.4% [387 of 1726; 95% CI: 20.5%-24.5%]; P < 0.001). The sensitivity for both cohorts was 100%. In women with negative findings on DBT or DM, supplemental US yielded similar CDRs in both DBT and DM cohorts (4.0 vs. 3.3 per 1000 examinations, respectively; P = 0.803) and higher AIR in the DBT cohort (24.8% [188 of 758; 95% CI: 21.8%-28.0%] vs. 16.9% [257 of 1516; 95% CI: 15.1%-18.9%; P < 0.001).
CONCLUSION: DBT screening combined with US showed comparable CDR but lower specificity than DM screening combined with US in women with dense breasts.
引用
- Ha SM, Yi A, Yim D, et al. Digital Breast Tomosynthesis Plus Ultrasound Versus Digital Mammography Plus Ultrasound for Screening Breast Cancer in Women With Dense Breasts. Korean J Radiol. 2023. PMID: 36996902. doi:10.3348/kjr.2022.0649
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。